7th Lab Asset and Facility Management Summit
When:
Monday, Nov 18, 2024 8:00a -
Wednesday, Nov 20, 2024 5:00p
Monday, Nov 18, 2024 8:00a -
Wednesday, Nov 20, 2024 5:00p
Where:
The Westin Boston Seaport District
425 Summer Street
Boston, Massachusetts 02210
Admission:
$2199.00 - $5097.00
Hosted by:
Categories:
Lectures & Conferences
Event website:
https://go.evvnt.com/2515958-0?pid=5248
Supercharge Your R and D, Diagnostic and GMP Operations Across Asset and Facilities' Productivity, Capital Efficiency and Sustainability through Integration and Automation Today
The lab operations and tech community are truly the machines that power expansions to enable quality, safe, and flexible working environments for end-users. Amid ongoing growth, efficiency is crucial. Optimizing equipment, workforce and space is now imperative to prepare facilities of the future.
In collaboration with Eli Lilly's COO, the 7th Lab Asset and Facility Management Summit (LAFM) is returning to Boston with 50+ speakers, new tracks, and a reimagined pre-conference day. The summit will unite 350+ lab operations, facilities, EHS, procurement and IT and automation professionals to leverage data from assets, facilities and procurement to influence cost-saving and efficiency decisions that contribute towards a transformative and smooth-running drug development environment.
Tailored towards biopharma, diagnostic labs, CDMO, CRO and academics looking to explore brand-new future expansion case studies, leveraging and integrating utilization data, LIMS, systems integration, and much more, LAFM will help paint the perfect picture for a solid working environment.
This collaborative meeting will empower you with the technical and soft skills to support your operational teams and scientists for the present and future.
URLs:
Tickets: https://go.evvnt.com/2515958-2?pid=5248
Brochure: https://go.evvnt.com/2515958-3?pid=5248
Prices:
Conference Only - Drug Developer: USD 2599.00,
Conference + 2 Workshops (Half Day) - Drug Developer: USD 3048.00,
Conference + 4 Workshops (Full Day)- Drug Developer: USD 3497.00,
Conference + Training Day (Full Day) - Drug Developer : USD 3497.00,
Conference Only - Not-For-Profit: USD 2199.00,
Conference + 2 Workshops (Half Day) - Not-For-Profit: USD 2548.00,
Conference + 4 Workshops (Full Day) - Not-For-Profit: USD 2987.00,
Conference + 4 Workshops (Full Day) - Vendor: USD 5097.00,
Conference Only - Vendor: USD 3699.00,
Conference + 2 Workshops (Half Day) - Vendor: USD 4398.00
Speakers: Ahmad Khan Director of Lab Operations Orchid, Alexis Anchundia Senior Facilities Engineer Noven Pharmaceuticals, Alysa Gonzalez Quality and Compliance Lead Pfizer, Amey Kanitkar Lab Operations Lead GSK, Anna Greenswag Director, Lab and Infrastructure Continuous Improvement Ginkgo Bioworks, Arup Dey Senior Manager, Lab Operations AbbVie, Ashley Banks Associate Director of Kendall Square Planning AstraZeneca, Bridget Byrne Senior Manager, Facilities and Operations Accent Therapeutics, Chris Gascon Head of Infrastructure Engineering Guardant Health, Christopher Colavito Senior Manager Facilities Operations Regeneron, Daniel O'Connell Associate Director of Facilities Alnylam Pharmaceuticals, Derek Sokolowski Product manager PHCbi, Divya Krishnamurthy Senior Director, Workplace Operations and Safety Lyndra Therapeutics, Dominic Franey Executive Director of Global Facilities Management Charles River Laboratories, Doug Martinez Manager, Laboratory and Infrastructure Continuous Improvement Ginkgo Bioworks, Drew Kimberlin Lab Operations and Facilities Manager Century Therapeutics, Faith Ann Lawlor Campus Manager, Business and Strategic Planning Johnson and Johnson, Gavin Finn President and Chief Executive Officer Lab Design Tool, Powered by Kaon Interactive, Gitte Pedersen Founder and Chief Operating Officer Genomic Expression, Jason Ho Senior Lab Operations Manager Deep Genomics, Jayson Bernstein Managing Director American Laboratory Trading, Jesse Mulcahy Director, Head of Automation Cellino, Jessica Beltran Director of Operations Lytica Therapeutics, Jillian Giguere Director, Lab Operations and Facilities Editas Medicine, John Curran Chief Operating Officer and Laboratory Director Pear Bio, Jorge Redondo Associate Director of Maintenance Lonza, Julie Griesbach OEM and Asset Management Sales Manager ZefSci, Keith Anderson Senior Manager, Lab Operations Cell Signaling Technology, Linwood Bryant Associate Director, Asset Management Regeneron Pharmaceuticals, Margaret Soucheray Lab Manager UCSF, Marisa Capone Planning and Inventory Management Lead Pfizer, Mark Spooner Laboratory Director Utah Tech University, Matthew Greenfield Senior Director, Laboratory Operations and Facilities Verve Therapeutics, Maureen O'Leary Associate Vice Provost for Research, Environmental Health and Radiation Safety University of Pennsylvania, Michael Harrison Chief Operations Officer - Cambridge Eli Lilly, Michael Serghiou Senior Director – Global Head of Discovery Research Procurement Takeda, Mike Korzelius Senior Sustainability Manager Crown Bio, Mobeen Gajee Head of Digital, Facilities and Lab Operations Prime Medicine, Nevin Gerek Ince Director, Data and Solutions Engineering Novo Nordisk, Pauline Serrano EHS Lead Sana Biotechnology, Peggy Weber Director of Laboratory Systems Sarepta Therapeutics, Piyali Sarkar Associate Director Amneal Pharmaceuticals, Praveen Malhotra Vice President, Head of Information Technology Sana Biotechnology, Radia Wahab Associate Director of Systems Engineering and Software Guardant Health, Randi Maki Senior Specialist, Capital Purchasing Merck, Renato Pedroso Site Engineering Head Takeda Pharmaceutical, Richard Teixeira Senior Director, Procurement Pfizer, Sridhar Iyengar Founder and Chief Strategy and Technology Officer Elemental Machines, Steve Sample Director of Facilities Sonoma Biotherapeutics, Susan Veres Former Vice President, Facilities and Business Risk Management Acorda Therapeutics, Timmy Carey Director Global EHS and S and Environmental Sustainability BioMarin Pharmaceutical, Todd Holman Senior Facility Manager Editas Medicine
